• This record comes from PubMed

Desferrioxamine B-Mediated Pre-Clinical In Vivo Imaging of Infection by the Mold Fungus Aspergillus fumigatus

. 2021 Sep 08 ; 7 (9) : . [epub] 20210908

Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic

Document type Journal Article

Grant support
KLI 909 Austrian Science Fund FWF - Austria
P 30924 Austrian Science Fund FWF - Austria

Fungal infections are a serious threat, especially for immunocompromised patients. Early and reliable diagnosis is crucial to treat such infections. The bacterially produced siderophore desferrioxamine B (DFO-B) is utilized by a variety of microorganisms for iron acquisition, while mammalian cells lack the uptake of DFO-B chelates. DFO-B is clinically approved for a variety of long-term chelation therapies. Recently, DFO-B-complexed gallium-68 ([68Ga]Ga-DFO-B) was shown to enable molecular imaging of bacterial infections by positron emission tomography (PET). Here, we demonstrate that [68Ga]Ga-DFO-B can also be used for the preclinical molecular imaging of pulmonary infection caused by the fungal pathogen Aspergillus fumigatus in a rat aspergillosis model. Moreover, by combining in vitro uptake studies and the chemical modification of DFO-B, we show that the cellular transport efficacy of ferrioxamine-type siderophores is impacted by the charge of the molecule and, consequently, the environmental pH. The chemical derivatization has potential implications for its diagnostic use and characterizes transport features of ferrioxamine-type siderophores.

See more in PubMed

Bongomin F., Gago S., Oladele R.O., Denning D.W. Global and multi-national prevalence of fungal diseases—Estimate precision. J. Fungi. 2017;3:57. doi: 10.3390/jof3040057. PubMed DOI PMC

Arastehfar A., Carvalho A., Houbraken J., Lombardi L., Garcia-Rubio R., Jenks J., Rivero-Menendez O., Aljohani R., Jacobsen I., Berman J., et al. Aspergillus fumigatus and aspergillosis: From basics to clinics. Stud. Mycol. 2021;100:100115. doi: 10.1016/j.simyco.2021.100115. PubMed DOI PMC

Kozel T.R., Wickes B. Fungal diagnostics. Cold Spring Harb. Perspect. Med. 2014;4:a019299. doi: 10.1101/cshperspect.a019299. PubMed DOI PMC

Kontoyiannis D.P., Sumoza D., Tarrand J., Bodey G.P., Storey R., Raad I.I. Significance of Aspergillemia in patients with cancer: A 10-year study. Clin. Infect. Dis. 2000;31:188–189. doi: 10.1086/313918. PubMed DOI

Thornton C.R. Detection of the ‘Big Five’ mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and Mucormycetes. Adv. Appl. Microbiol. 2020;110:1–61. PubMed

Barnes R.A. Early diagnosis of fungal infection in immunocompromised patients. J. Antimicrob. Chemother. 2008;61:i3–i6. doi: 10.1093/jac/dkm424. PubMed DOI

Palmer L.D., Skaar E.P. Transition metals and virulence in bacteria. Annu. Rev. Genet. 2016;50:67–91. doi: 10.1146/annurev-genet-120215-035146. PubMed DOI PMC

Misslinger M., Hortschansky P., Brakhage A.A., Haas H. Fungal iron homeostasis with a focus on Aspergillus fumigatus. Biochim. Biophys. Acta (BBA) Bioenerg. 2020;1868:118885. doi: 10.1016/j.bbamcr.2020.118885. PubMed DOI

Latgé J.-P., Chamilos G. Aspergillus fumigatus and Aspergillosis in 2019. Clin. Microbiol. Rev. 2019;33:e00140-18. doi: 10.1128/CMR.00140-18. PubMed DOI PMC

Schrettl M., Bignell E., Kragl C., Joechl C., Rogers T., Arst H.N., Haynes K., Haas H. Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J. Exp. Med. 2004;200:1213–1219. doi: 10.1084/jem.20041242. PubMed DOI PMC

Petrik M., Franssen G.M., Haas H., Laverman P., Hörtnagl C., Schrettl M., Helbok A., Lass-Flörl C., Decristoforo C. Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging. Eur. J. Nucl. Med. Mol. Imaging. 2012;39:1175–1183. doi: 10.1007/s00259-012-2110-3. PubMed DOI PMC

Petrik M., Haas H., Schrettl M., Helbok A., Blatzer M., Decristoforo C. In vitro and in vivo evaluation of selected 68Ga-siderophores for infection imaging. Nucl. Med. Biol. 2012;39:361–369. doi: 10.1016/j.nucmedbio.2011.09.012. PubMed DOI PMC

Bickel H., Gäumann E., Keller-Schierlein W., Prelog V., Vischer E., Wettstein A., Zähner H. Über eisenhaltige wachstumsfaktoren, die sideramine, und ihre antagonisten, die eisenhaltigen antibiotika sideromycine. Cell. Mol. Life Sci. 1960;16:129–133. doi: 10.1007/BF02157712. PubMed DOI

Polsinelli I., Borruso L., Caliandro R., Triboli L., Esposito A., Benini S. A genome-wide analysis of desferrioxamine mediated iron uptake in Erwinia spp. reveals genes exclusive of the Rosaceae infecting strains. Sci. Rep. 2019;9:2818. doi: 10.1038/s41598-019-39787-x. PubMed DOI PMC

Challis G.L. A widely distributed bacterial pathway for siderophore biosynthesis independent of nonribosomal peptide synthetases. ChemBioChem. 2005;6:601–611. doi: 10.1002/cbic.200400283. PubMed DOI

Petrik M., Pfister J., Misslinger M., Decristoforo C., Haas H. Siderophore-based molecular imaging of fungal and bacterial infections—Current status and future perspectives. J. Fungi. 2020;6:73. doi: 10.3390/jof6020073. PubMed DOI PMC

Fadeev E.A., Luo M., Groves J.T. Synthesis, structure, and molecular dynamics of gallium complexes of schizokinen and the amphiphilic siderophore acinetoferrin. J. Am. Chem. Soc. 2004;126:12065–12075. doi: 10.1021/ja048145j. PubMed DOI

Bellotti D., Remelli M. Deferoxamine B: A natural, excellent and versatile metal chelator. Molecules. 2021;26:3255. doi: 10.3390/molecules26113255. PubMed DOI PMC

Velasquez J., Wray A.A. Deferoxamine. StatPearls Publishing; Treasure Island, FL, USA: 2021.

Desferal Vials—Summary of Product Characteristics (SmPC) [(accessed on 8 July 2021)]. Available online: https://www.medicines.org.uk/emc/product/3813/smpc#gref.

Petrik M., Umlaufova E., Raclavsky V., Palyzova A., Havlicek V., Pfister J., Mair C., Novy Z., Popper M., Hajduch M., et al. 68Ga-labelled desferrioxamine-B for bacterial infection imaging. Eur. J. Nucl. Med. Mol. Imaging. 2020;48:372–382. doi: 10.1007/s00259-020-04948-y. PubMed DOI PMC

Luptáková D., Pluháček T., Petrik M., Novak J., Palyzová A., Sokolová L., Škríba A., Šedivá B., Lemr K., Havlíček V. Non-invasive and invasive diagnoses of aspergillosis in a rat model by mass spectrometry. Sci. Rep. 2017;7:16523. doi: 10.1038/s41598-017-16648-z. PubMed DOI PMC

Pfister J., Bata R., Hubmann I., Hörmann A.A., Gsaller F., Haas H., Decristoforo C. Siderophore scaffold as carrier for antifungal peptides in therapy of Aspergillus Fumigatus infections. J. Fungi. 2020;6:367. doi: 10.3390/jof6040367. PubMed DOI PMC

Kaeopookum P., Summer D., Pfister J., Orasch T., Lechner B.E., Petrik M., Novy Z., Matuszczak B., Rangger C., Haas H., et al. Modifying the siderophore triacetylfusarinine C for molecular imaging of fungal infection. Mol. Imaging Biol. 2019;21:1097–1106. doi: 10.1007/s11307-019-01325-6. PubMed DOI PMC

Hartmann T., Dümig M., Jaber B.M., Szewczyk E., Olbermann P., Morschhäuser J., Krappmann S. Validation of a self-excising marker in the human pathogen Aspergillus fumigatus by employing the β-Rec/six site-specific recombination system. Appl. Environ. Microbiol. 2010;76:6313–6317. doi: 10.1128/AEM.00882-10. PubMed DOI PMC

Pontecorvo G., Roper J., Chemmons L., Macdonald K., Bufton A. The genetics of Aspergillus nidulans. Adv. Genet. 1953;5:141–238. doi: 10.1016/s0065-2660(08)60408-3. PubMed DOI

Schrettl M., Kim H., Eisendle M., Kragl C., Nierman W.C., Heinekamp T., Werner E.R., Jacobsen I.D., Illmer P., Yi H., et al. SreA-mediated iron regulation in Aspergillus fumigatus. Mol. Microbiol. 2008;70:27–43. doi: 10.1111/j.1365-2958.2008.06376.x. PubMed DOI PMC

Gunzer M., Thornton C.R., Beziere N. Advances in the in vivo molecular imaging of invasive Aspergillosis. J. Fungi. 2020;6:338. doi: 10.3390/jof6040338. PubMed DOI PMC

Anderson C.J., Ferdani R. Copper-64 radiopharmaceuticals for PET imaging of cancer: Advances in preclinical and clinical research. Cancer Biother. Radiopharm. 2009;24:379–393. doi: 10.1089/cbr.2009.0674. PubMed DOI PMC

Price E.W., Orvig C. Matching chelators to radiometals for radiopharmaceuticals. Chem. Soc. Rev. 2013;43:260–290. doi: 10.1039/C3CS60304K. PubMed DOI

Rangger C., Haubner R. Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology. Pharmaceuticals. 2020;13:22. doi: 10.3390/ph13020022. PubMed DOI PMC

Rosebrough S.F. Plasma stability and pharmacokinetics of radiolabeled deferoxamine-biotin derivatives. J. Pharmacol. Exp. Ther. 1993;265:408–415. PubMed

Petrik M., Haas H., Laverman P., Schrettl M., Franssen G.M., Blatzer M., Decristoforo C. 68Ga-triacetylfusarinine C and 68Ga-ferrioxamine E for Aspergillus infection imaging: Uptake specificity in various microorganisms. Mol. Imaging Biol. 2013;16:102–108. doi: 10.1007/s11307-013-0654-7. PubMed DOI PMC

Kaplan C., Kaplan J. Iron acquisition and transcriptional regulation. Chem. Rev. 2009;109:4536–4552. doi: 10.1021/cr9001676. PubMed DOI

Spitzer K.W., Vaughan-Jones R.D. Regulation of intracellular pH in mammalian cells. In: Karmazyn M., Avkiran M., Fliegel L., editors. The Sodium-Hydrogen Exchanger. Springer; Boston, MA, USA: 2003. pp. 1–15. DOI

Ganz T. Iron in innate immunity: Starve the invaders. Curr. Opin. Immunol. 2009;21:63–67. doi: 10.1016/j.coi.2009.01.011. PubMed DOI PMC

Nairz M., Weiss G. Iron in infection and immunity. Mol. Asp. Med. 2020;75:100864. doi: 10.1016/j.mam.2020.100864. PubMed DOI

Pfister J., Petrik M., Bendova K., Matuszczak B., Binder U., Misslinger M., Kühbacher A., Gsaller F., Haas H., Decristoforo C. Antifungal siderophore conjugates for theranostic applications in invasive pulmonary aspergillosis using low-molecular TAFC scaffolds. J. Fungi. 2021;7:558. doi: 10.3390/jof7070558. PubMed DOI PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...